Prosecution Insights
Last updated: April 19, 2026

Examiner: TIEN, LUCY MINYU

Tech Center 1600 • Art Units: 1612

This examiner grants 62% of resolved cases

Performance Statistics

62.5%
Allow Rate
+2.5% vs TC avg
126
Total Applications
+32.9%
Interview Lift
1120
Avg Prosecution Days
Based on 72 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
6.4%
§102 Novelty
46.8%
§103 Obviousness
25.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18301004 Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols Final Rejection Symrise AG
18009284 Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols Non-Final OA Symrise AG
18041973 DOPA MODIFIED GELATIN FOR WOUND HEALING AND METHODS OF MAKING THE SAME Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18713856 HAIR CLEANSING COMPOSITION Non-Final OA KAO CORPORATION
17953392 SKIN CONDITIONING COMPOSITION WITH HIGH CONCENTRATION OF UREA TO BOOST THE SKINCARE ACTIVES Non-Final OA L'OREAL
18514903 COMPOSITIONS AND METHODS FOR TREATING DEPRESSION AND ANXIETY Non-Final OA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
18529500 USE OF A COMPOSITE MATERIAL Non-Final OA Heraeus Medical GmbH
18684543 SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Non-Final OA Bayer Aktiengesellschaft
18344001 COLORING SOLUTIONS FOR GUM TISSUE COLOR MATCH FOR ZIRCONIA PROSTHESIS Final Rejection James R. Glidewell Dental Ceramics, Inc.
17686880 PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF Non-Final OA Boehringer Ingelheim International GmbH
17903255 HERBICIDAL COMPOSITIONS COMPRISING FLUAZIFOP, TRICLOPYR AND DIQUAT Non-Final OA BAYER CROPSCIENCE LP
17309624 Compositions of Bedaquiline, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them Non-Final OA MannKind Corporation
18285570 SILICA-BASED FORMULATIONS OF THERAPEUTIC OLIOGPEPTIDES AND PEPTIDOMIMETICS Non-Final OA Stealth BioTherapeutics Inc.
18709952 ANTIVIRAL AGENT, ANTIVIRAL PRODUCT, AND ANTIVIRAL TREATMENT LIQUID Non-Final OA Kyodo Printing Co., Ltd.
18001936 NOVEL ANTIBACTERIAL HYDROGELS Final Rejection NewSouth Innovations Pty Limited
18549612 AN OLEOGEL COMPOSITION COMPRISING AN ETHYLCELLULOSE AND AN OILY ACTIVE INGREDIENT Final Rejection NUTRITION & BIOSCIENCES USA 1, LLC
18039231 QUICK RELEASE INSECTICIDAL COMPOSITION Non-Final OA UPL Limited
18690286 POROUS TITANIUM ALLOY STRUCTURE WITH A SILVER COATING HAVING OSTEOCOMPATIBILITY AND ANTIMICROBIAL PROPERTIES Non-Final OA WALDEMAR LINK GMBH & CO. KG
18554687 METHOD OF INHIBITING FLOWERING OF SUGARCANE Final Rejection CORTEVA AGRISCIENCE LLC
18684555 SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Non-Final OA BayerAktiengesellschaft
17906512 ORAL TERPENE CYCLODEXTRIN INCLUSION COMPLEX VEHICLES Non-Final OA CZAP RESEARCH AND DEVELOPMENT, LLC.
18573044 COSMETIC COMPOSITION FOR THE HAIR AND USE THEREOF FOR HAIR AND/OR SCALP CARE Non-Final OA PIERRE FABRE DERMO-COSMETIQUE
18530276 Composite Nano-agent for Combating Drug-fast Bacteria and Preparation Method Thereof Non-Final OA Guangdong Medical University
17769195 STABILIZED CONAZOLE COMPOSITION Final Rejection UPL EUROPE LTD
18563204 STABLE LIQUID PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO Non-Final OA CERECIN INC.
18562719 MPLA COMPOSITIONS AND METHODS OF USE Non-Final OA Revelation Biosciences, Inc.
18284085 AGRICULTURAL FORMULATIONS Final Rejection Stepan Company
18382741 TOPICAL ANTISEPTIC Final Rejection SurgiWipe LLC
18556513 SILICON PARTICLES FOR DRUG DELIVERY Non-Final OA NACAMED AS
18264930 COMPOSITION FOR ORAL CAVITY CARE Final Rejection ICHIMARU PHARCOS CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month